CME vs PRAX · P/E 22, rev $3.59B vs $7.38B cap
CME Group Inc (CME) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
CME currently screens at market cap $91.25B and trailing P/E 21.9. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the CME and PRAX stock pages for the full models.
Not investment advice.